本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Eagle製藥

1.94
0.0000
成交量:- -
成交額:- -
市值:2,526.49萬
市盈率:2.13
高:1.94
開:1.94
低:1.94
收:1.94
資料載入中...
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

重要事件披露

Form 8-K - Current report
2024/11/26

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/05

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/09

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/02

重要事件披露

Form 8-K - Current report
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/05

重要事件披露

Form 8-K - Current report